Related Experiment Video
Updated: Jul 13, 2025

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
Published on: November 26, 2010
SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer
Alireza Tojjari1, Francis J Giles2, Maysa Vilbert1
1Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 15213, USA.
Abstract:
In the field of oncology, the Signaling Lymphocyte Activation Molecule (SLAM) family is emerging as pivotal in modulating immune responses within tumor environments. The SLAM family comprises nine receptors, mainly found on immune cell surfaces. These receptors play complex roles in the interaction between cancer and the host immune system. Research suggests SLAM's role in both enhancing and dampening tumor-immune responses, influencing the progression and treatment outcomes of various cancers. As immunotherapy advances, resistance remains an issue. The nuanced roles of the SLAM family might provide answers. With the rise in technologies like single-cell RNA sequencing and advanced imaging, there is potential for precise SLAM-targeted treatments. This review stresses patient safety, the importance of thorough clinical trials, and the potential of SLAM-focused therapies to transform cancer care. In summary, SLAM's role in oncology signals a new direction for more tailored and adaptable cancer treatments.
Insights
The Signaling Lymphocyte Activation Molecule (SLAM) family influences cancer immunity, offering new therapeutic targets. Understanding SLAM
Area of Science:
- Oncology and Immunology
Background:
- The Signaling Lymphocyte Activation Molecule (SLAM) family, comprising nine receptors on immune cells, plays a complex role in tumor-immune interactions.
- SLAM receptors are increasingly recognized for their dual function in modulating anti-tumor immune responses, impacting cancer progression and treatment efficacy.
Purpose of the Study:
- To review the multifaceted roles of the SLAM family in oncology.
- To explore the potential of SLAM-targeted therapies in overcoming immunotherapy resistance and advancing personalized cancer treatment.
Main Methods:
- Literature review of current research on SLAM family receptors in cancer immunology.
- Analysis of emerging technologies like single-cell RNA sequencing and advanced imaging for SLAM-based therapeutic development.
Main Results:
- SLAM family receptors exhibit diverse functions, potentially enhancing or suppressing anti-tumor immunity.
- The SLAM family's complex roles present opportunities for novel immunotherapeutic strategies.
- Advanced technologies facilitate precise targeting of SLAM pathways for cancer treatment.
Conclusions:
- Targeting the SLAM family offers a promising avenue for developing tailored and adaptable cancer therapies.
- Further research and rigorous clinical trials are essential to ensure patient safety and therapeutic success.
- SLAM-focused approaches may significantly transform future cancer care paradigms.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation

